Biotage AB (publ)
BIOT.ST
141.5
SEK+0.30
(+0.21%)Day's range
141.3
142.1
52 wk Range
81.6
202.2
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 1,092,278,000 | 1,232,000,000 | 1,566,000,000 | 1,862,000,000 | 2,056,000,000 | |
| Gross Profit | 666,728,000 | 755,000,000 | 948,000,000 | 1,013,000,000 | 1,289,000,000 | |
| Operating Income | 206,185,000 | 271,000,000 | 327,000,000 | 376,000,000 | 383,000,000 | |
| Net Income | 175,000,000 | 205,000,000 | 268,000,000 | 246,000,000 | 284,000,000 | |
| Total Assets | 1,434,441,000 | 1,992,000,000 | 2,339,000,000 | 4,931,000,000 | 5,104,000,000 | |
| Total Current Liabilities | 217,364,000 | 313,000,000 | 417,000,000 | 705,000,000 | 582,000,000 | |
| Total Equity | 990,038,000 | 1,372,000,000 | 1,637,000,000 | 3,657,000,000 | 4,113,000,000 | |
| Free Cash Flow | 218,106,000 | 297,000,000 | 271,000,000 | 258,000,000 | 244,000,000 | |
| Cash from Operations | 279,047,000 | 353,000,000 | 341,000,000 | 284,000,000 | 413,000,000 | |
| Cash from Investing | -61,320,000 | -341,000,000 | -84,000,000 | 35,000,000 | -456,000,000 | |
| Cash from Financing | -22,723,000 | -82,000,000 | -133,000,000 | -142,000,000 | -156,000,000 | |
| Net Change in Cash | 185,458,000 | -60,000,000 | 130,000,000 | 153,000,000 | -160,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy